Ottonomy Raises Series A from Enrission to Scale Hospital Robots

Autonomous delivery robot maker Ottonomy IO has closed a Series A round from Japanese venture capital firm Enrission India Capital, with terms undisclosed and the investment flowing through Enrission's "Enrission SP26 India" fund, according to Dealroom.

The announcement landed in November 2026. It's the second outside bet on the Santa Monica company in two months — and both checks point at the same thesis: hospitals need machines to move stuff so nurses don't have to.

What does Ottonomy actually build?

Founded in 2020 and based in Santa Monica, California, Ottonomy makes "Ottobot" robots that move goods across indoor and outdoor environments. The technical hook is what the company calls "context AI": a stack combining video recognition, ultrasonic sensors, and edge computing that lets the robots navigate spaces where GPS fails.

The bots aren't confined to a single floor. API links to elevator controllers let them travel across multiple floors unmanned — the difference between a demo unit and a machine that can actually run errands inside a hospital.

Why are investors writing checks now?

The numbers behind the round are stark. The US faces a projected shortage of more than 300,000 nurses nationwide by 2036. Nurses reportedly spend about half their time on non-clinical tasks such as moving supplies.

That's the gap Ottonomy is selling into. Its business centers on medical facilities, with deployments already running at US health systems and global firms. The company plans to:

• Expand further within healthcare
• Enter new global markets
• Launch software to manage multiple robots at once

The fleet-management software matters if deployments grow from a handful of pilots to dozens of units per site. One robot is a gadget; a managed fleet is infrastructure.

Who else has backed the company?

This isn't Ottonomy's first capital. In September 2026, Nasdaq-listed Gix Internet announced a $500,000 investment via a SAFE — a simple agreement for future equity — plus a non-binding proposal that could eventually hand Gix a majority stake in the company.

On the ground, Ottonomy's hospital work includes an operating system built with Arrive AI for moving medical supplies and lab samples at Hancock Regional Hospital. That's a concrete, named deployment — lab samples and supplies, moved by robot, inside a working US hospital.

How big is the round?

Nobody's saying. The deal discloses no amount and no valuation. The $500,000 Gix SAFE in September suggests Ottonomy was raising comparatively modest sums very recently, and the Series A from Enrission's "Enrission SP26 India" fund arrives without evidence of broad commercial scale.

What the round does show is a follow-on bet on a company with existing pilots rather than an untested idea. Ottonomy has named deployments, named partners, and now two investors across two continents.

What's the signal for the sector?

Labor shortages are hitting both US and Japanese healthcare, and investors are backing "physical AI" as potential infrastructure for medical and industrial logistics, per Dealroom's analysis.

The caveat is as clear as the thesis: no disclosed amount, no disclosed valuation, and no public proof of mass deployment. If Ottonomy's fleet-management software ships and hospital contracts multiply, the undisclosed round stops mattering. Until then, it's a well-positioned pilot company with patient capital behind it.